D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 89 Citations 34,504 534 World Ranking 7906 National Ranking 769

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Disease

Simon Travis mainly investigates Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Surgery and Gastroenterology. His study in the fields of Mesalazine under the domain of Inflammatory bowel disease overlaps with other disciplines such as Context. His studies in Ulcerative colitis integrate themes in fields like Physical therapy, Clinical trial, Colitis and Pharmacotherapy.

He combines subjects such as Colectomy, Management of Crohn's disease and Intensive care medicine with his study of Surgery. His Gastroenterology research is multidisciplinary, incorporating perspectives in Colonoscopy, Sigmoidoscopy and Placebo. His biological study spans a wide range of topics, including Evidence-based practice, Intestinal mucosa, Immunology and Single-nucleotide polymorphism.

His most cited work include:

  • The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management (1239 citations)
  • The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis (1222 citations)
  • Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (1018 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Ulcerative colitis, Gastroenterology, Inflammatory bowel disease and Crohn's disease. Many of his studies involve connections with topics such as Surgery and Internal medicine. His Surgery research includes themes of Odds ratio and Placebo.

His study looks at the relationship between Ulcerative colitis and topics such as Colitis, which overlap with Management of ulcerative colitis. His Gastroenterology study combines topics from a wide range of disciplines, such as Budesonide, Mesalazine, Adverse effect, Calprotectin and Colonoscopy. Simon Travis has included themes like Quality of life, Immunology and Primary sclerosing cholangitis in his Inflammatory bowel disease study.

He most often published in these fields:

  • Internal medicine (57.31%)
  • Ulcerative colitis (42.13%)
  • Gastroenterology (33.21%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (57.31%)
  • Ulcerative colitis (42.13%)
  • Inflammatory bowel disease (26.19%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Ulcerative colitis, Inflammatory bowel disease, Crohn's disease and Gastroenterology. Simon Travis merges Internal medicine with In patient in his study. His Colectomy study, which is part of a larger body of work in Ulcerative colitis, is frequently linked to Calculator, bridging the gap between disciplines.

His Inflammatory bowel disease research includes elements of Exome sequencing, Malignancy, Immunology and Intensive care medicine. His research on Crohn's disease concerns the broader Disease. As a part of the same scientific family, he mostly works in the field of Gastroenterology, focusing on Confidence interval and, on occasion, Histopathology, Area under the curve and Receiver operating characteristic.

Between 2018 and 2021, his most popular works were:

  • Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis. (24 citations)
  • Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis. (24 citations)
  • Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease (18 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Cancer

Internal medicine, Inflammatory bowel disease, Crohn's disease, Gastroenterology and Ulcerative colitis are his primary areas of study. Simon Travis performs integrative study on Internal medicine and In patient. Simon Travis has researched Inflammatory bowel disease in several fields, including Immunology, Transplantation and Intensive care medicine.

His Crohn's disease study is focused on Disease in general. His work carried out in the field of Gastroenterology brings together such families of science as Osteomalacia, Refractory and Surrogate endpoint. Many of his research projects under Ulcerative colitis are closely connected to MedDRA with MedDRA, tying the diverse disciplines of science together.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

A. Dignass;G. Van Assche;J.O. Lindsay;M. Lémann.
Journal of Crohns & Colitis (2010)

1672 Citations

Guidelines for the management of inflammatory bowel disease in adults

M J Carter;A J Lobo;S P L Travis.
Gut (2004)

1488 Citations

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch.
The American Journal of Gastroenterology (2015)

1442 Citations

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Wolfgang Hueber;Bruce E Sands;Steve Lewitzky;Marc Vandemeulebroecke.
Gut (2012)

1310 Citations

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

Gert Van Assche;Axel Dignass;Julian Panes;Laurent Beaugerie.
Gut (2006)

1290 Citations

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

Axel Dignass;James O. Lindsay;Andreas Sturm;Alastair Windsor.
Journal of Crohn's and Colitis (2012)

1260 Citations

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

Gert Van Assche;Axel Dignass;Walter Reinisch;C. Janneke van der Woude.
Journal of Crohns & Colitis (2010)

1192 Citations

Second European Evidence-Based Consensus on the Diagnosis and Management of Ulcerative Colitis Part 1: Definitions and Diagnosis

Axel Dignass;Rami Eliakim;Fernando Magro;Christian Maaser.
Journal of Crohn's and Colitis (2012)

1022 Citations

Mucosal healing in inflammatory bowel diseases: a systematic review

Markus F Neurath;Simon P L Travis.
Gut (2012)

843 Citations

Predicting outcome in severe ulcerative colitis.

S. P. L. Travis;J. M. Farrant;C. Ricketts;D. J. Nolan.
Gut (1996)

842 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Simon Travis

Laurent Peyrin-Biroulet

Laurent Peyrin-Biroulet

University of Lorraine

Publications: 318

William J. Sandborn

William J. Sandborn

University of California, San Diego

Publications: 253

Silvio Danese

Silvio Danese

Humanitas University

Publications: 189

Severine Vermeire

Severine Vermeire

KU Leuven

Publications: 173

Jean-Frederic Colombel

Jean-Frederic Colombel

Icahn School of Medicine at Mount Sinai

Publications: 172

Brian G. Feagan

Brian G. Feagan

University of Western Ontario

Publications: 165

Javier P. Gisbert

Javier P. Gisbert

Autonomous University of Madrid

Publications: 141

Peter L. Lakatos

Peter L. Lakatos

McGill University

Publications: 139

Geert R. D'Haens

Geert R. D'Haens

University of Amsterdam

Publications: 115

Gerhard Rogler

Gerhard Rogler

University of Zurich

Publications: 114

David T. Rubin

David T. Rubin

University of Chicago

Publications: 101

Walter Reinisch

Walter Reinisch

Medical University of Vienna

Publications: 101

Paul Rutgeerts

Paul Rutgeerts

KU Leuven

Publications: 100

Subrata Ghosh

Subrata Ghosh

University College Cork

Publications: 94

Remo Panaccione

Remo Panaccione

University of Calgary

Publications: 93

Gert Van Assche

Gert Van Assche

KU Leuven

Publications: 92

Trending Scientists

Nico Heerink

Nico Heerink

Wageningen University & Research

Christos Tzivanidis

Christos Tzivanidis

National Technical University of Athens

Jürgen Caro

Jürgen Caro

University of Hannover

Jan Klein

Jan Klein

Pennsylvania State University

Joseph L. DeRisi

Joseph L. DeRisi

University of California, San Francisco

Susumu Ohno

Susumu Ohno

City Of Hope National Medical Center

John Lyons

John Lyons

Wisconsin Department of Natural Resources

Bruno P. A. Cammue

Bruno P. A. Cammue

KU Leuven

Sharon Gerecht

Sharon Gerecht

Johns Hopkins University

Qijun Chen

Qijun Chen

Peking Union Medical College Hospital

Ian Phillips

Ian Phillips

University College London

Steven E. Lindow

Steven E. Lindow

University of California, Berkeley

Anne F. Sheehan

Anne F. Sheehan

University of Colorado Boulder

Qiuhong Tang

Qiuhong Tang

Chinese Academy of Sciences

Christoph M. Michel

Christoph M. Michel

University of Geneva

Robert C. MacCallum

Robert C. MacCallum

University of North Carolina at Chapel Hill

Something went wrong. Please try again later.